PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

6 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Heinrich, N.* et al.: Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): A prospective, open-label, randomised, phase 2b dose-finding trial. Lancet Infect. Dis., DOI: 10.1016/S1473-3099(25)00213-0 (2025)
2.
Minja, L.T.* et al.: Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): A prospective, randomised, open-label, phase 2b, dose-finding trial. Lancet Infect. Dis., DOI: 10.1016/S1473-3099(25)00289-0 (2025)
3.
Kocher, K.* et al.: Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual. Lancet Infect. Dis. 24, e272-e274 (2024)
4.
Olbrich, L.* et al.: Sequential and parallel testing for microbiological confirmation of tuberculosis disease in children in five low-income and middle-income countries: A secondary analysis of the RaPaed-TB study. Lancet Infect. Dis. 25, 188-197 (2024)
5.
Olbrich, L.* et al.: Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countries. Lancet Infect. Dis. 24, 140-149 (2023)
6.
Tenbusch, M.* et al.: Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2. Lancet Infect. Dis. 21, 1212-1213 (2021)